Cambridge Investment Research Advisors’s abrdn Bloomberg All Commodity Strategy K-1 Free ETF BCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
65,485
+635
+1% +$15.4K ﹤0.01% 1800
2026
Q1
$1.57M Buy
64,850
+18,400
+40% +$403K ﹤0.01% 1798
2025
Q4
$907K Buy
46,450
+15,167
+48% +$337K ﹤0.01% 2174
2025
Q3
$674K Sell
31,283
-1,873
-6% -$39.3K ﹤0.01% 2388
2025
Q2
$689K Sell
33,156
-10,200
-24% -$212K ﹤0.01% 2243
2025
Q1
$930K Buy
43,356
+1,609
+4% +$33.6K ﹤0.01% 1925
2024
Q4
$824K Buy
41,747
+1,669
+4% +$33.6K ﹤0.01% 2024
2024
Q3
$819K Buy
40,078
+2,423
+6% +$47.8K ﹤0.01% 2013
2024
Q2
$766K Sell
37,655
-2,574
-6% -$53K ﹤0.01% 1964
2024
Q1
$795K Buy
40,229
+23,084
+135% +$446K ﹤0.01% 1892
2023
Q4
$332K Sell
17,145
-1,894
-10% -$39K ﹤0.01% 2514
2023
Q3
$402K Sell
19,039
-15,328
-45% -$324K ﹤0.01% 2265
2023
Q2
$693K Sell
34,367
-349
-1% -$7.11K ﹤0.01% 1887
2023
Q1
$721K Buy
34,716
+1,410
+4% +$29.7K ﹤0.01% 1803
2022
Q4
$735K Buy
33,306
+4,596
+16% +$119K ﹤0.01% 1728
2022
Q3
$742K Sell
28,710
-15,851
-36% -$433K ﹤0.01% 1677
2022
Q2
$1.21M Sell
44,561
-39,163
-47% -$1.17M 0.01% 1340
2022
Q1
$2.4M Buy
83,724
+57,091
+214% +$1.5M 0.01% 1027
2021
Q4
$612K Buy
26,633
+1,756
+7% +$48.3K ﹤0.01% 1946
2021
Q3
$698K Buy
24,877
+1,091
+5% +$29.1K ﹤0.01% 1793
2021
Q2
$627K Buy
+23,786
New +$602K ﹤0.01% 1880
2020
Q4
Sell
-21,054
Closed -$419K 2714
2020
Q3
$419K Buy
21,054
+7,956
+61% +$157K ﹤0.01% 1719
2020
Q2
$239K Buy
13,098
+211
+2% +$3.74K ﹤0.01% 2053
2020
Q1
$225K Buy
+12,887
New +$264K ﹤0.01% 1856

Other funds holding BCI

Cambridge Investment Research Advisors's BCI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI) stake by 0.98% in Q2 2026, buying an estimated $15.4K and bringing the position to 65,485 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Cambridge Investment Research Advisors first reported a position in BCI in Q1 2020 and has held it in 24 quarters since. The position peaked at $2.4M in Q1 2022. 53 funds tracked by Wall St. Rank hold BCI as of Q2 2026.

  • Cambridge Investment Research Advisors held 65,485 shares of abrdn Bloomberg All Commodity Strategy K-1 Free ETF worth $1.46M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 635 abrdn Bloomberg All Commodity Strategy K-1 Free ETF shares in Q2 2026, an estimated $15.4K.
  • abrdn Bloomberg All Commodity Strategy K-1 Free ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1800 holding.
  • Cambridge Investment Research Advisors first reported a position in abrdn Bloomberg All Commodity Strategy K-1 Free ETF in Q1 2020 and has held it in 24 quarters since.
  • Cambridge Investment Research Advisors's abrdn Bloomberg All Commodity Strategy K-1 Free ETF position peaked at $2.4M in Q1 2022.
  • 53 funds tracked by Wall St. Rank held abrdn Bloomberg All Commodity Strategy K-1 Free ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.